InvestorsHub Logo
Followers 13
Posts 2194
Boards Moderated 0
Alias Born 05/30/2012

Re: janeyH post# 6887

Monday, 07/18/2022 10:57:05 AM

Monday, July 18, 2022 10:57:05 AM

Post# of 6939
They finished selling off their IL-6 antagonist and announced they are not wasting time and money on a new trial with the FDA in the US.

What they are doing is preserving assets for the sale of the company .

They will take the employee count to a skeleton crew, only those needed to inventory and process the sales contract .

That is why they took the reverse off the table, no need to further dilute and raise money.

Jmo